STEPHEN DONNELLY: Open Payments
NPI 1144773383 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 9 payments from 7 companies in 2025. Trend: 2023 $242 · 2024 $215 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $64 |
| PFIZER INC. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Caris MPI, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: IBRANCE, ERLEADA, DARZALEX, Nubeqa, MI CANCER SEEK, KEYTRUDA QLEX, ZEJULA, LIBTAYO.
Industry payments across PA — which companies pay providers there.
